Also known as: BV-araU; 1-beta-D-Arabinofuranosyl-(E)-5-(2-bromovinyl)uracil
Sorivudine is a potent antiviral nucleoside analogue active against varicella-zoster virus (VZV) and Epstein-Barr virus. It inhibits viral DNA polymerase and was developed as an effective treatment for herpes zoster in immunocompromised patients. Mediocon Inc manufactures GMP-compliant Sorivudine API at its Aurangabad facility.
| Parameter | Specification |
|---|---|
| CAS Number | 77181-69-2 |
| Molecular Formula | C₁₁H₁₃BrN₂O₅ |
| Molecular Weight | 349.14 g/mol |
| Grade | IP / BP / EP / USP |
| Category | Antiviral / Nucleoside Analogue |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Batch No | SR/25030255 |
| Mfg Date | MAR 2025 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |